SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-21-008442
Filing Date
2021-08-12
Accepted
2021-08-12 16:06:01
Documents
52
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 hgen10qq2-2021.htm   iXBRL 10-Q 1098196
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 71188
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 66837
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 7941
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 7990
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4232
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 4433
13 GRAPHIC clinpipe.jpg GRAPHIC 52126
  Complete submission text file 0001214659-21-008442.txt   3817295

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE hgen-20210630.xsd EX-101.SCH 27954
9 XBRL CALCULATION FILE hgen-20210630_cal.xml EX-101.CAL 29922
10 XBRL DEFINITION FILE hgen-20210630_def.xml EX-101.DEF 85528
11 XBRL LABEL FILE hgen-20210630_lab.xml EX-101.LAB 197506
12 XBRL PRESENTATION FILE hgen-20210630_pre.xml EX-101.PRE 169737
14 EXTRACTED XBRL INSTANCE DOCUMENT hgen10qq2-2021_htm.xml XML 342171
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 211167500
SIC: 2834 Pharmaceutical Preparations